local_hospital

Centrum kardiovaskulární a transplantační chirurgie Brno

Address
Pekařská 664/53, Brno, Czechia

Centrum kardiovaskulární a transplantační chirurgie Brno

The Centrum kardiovaskulární a transplantační chirurgie Brno (Center for Cardiovascular and Transplantation Surgery Brno) is a specialized medical research facility focused on advanced cardiac and transplantation surgical procedures. The center conducts cutting-edge clinical trials in cardiovascular medicine, with particular emphasis on optimizing surgical outcomes and managing complex perioperative conditions.

  • Cardiopulmonary bypass procedures and anticoagulation management
  • Acquired antithrombin deficiency and heparin resistance in cardiac surgery
  • Novel therapeutic interventions for cardiovascular surgical patients

The center's research portfolio includes Phase 3 studies evaluating human plasma-derived antithrombin therapy for patients experiencing heparin resistance during cardiac surgery. This work addresses critical challenges in maintaining appropriate anticoagulation during cardiopulmonary bypass, a potentially life-threatening complication in cardiac surgical procedures. By investigating optimal dosing strategies and therapeutic protocols, the center contributes to improving safety and efficacy outcomes for patients requiring complex cardiovascular interventions.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
1
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
1
Outperforms 5% of sites
public
Therapeutic diversity
1areas
Outperforms 5% of sites
groups
Sponsor diversity
1sponsors
Outperforms 5% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centrum kardiovaskulární a transplantační chirurgie Brno

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety of Human Plasma-Derived Antithrombin in Heparin-Resistant Patients Undergoing Cardiopulmonary Bypass Cardiac SurgeryOctapharma AGPhase IIIRecruitingJan 2025

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Antithrombin Iii Human1Unknown2025-01-072025-01-07

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.